Company LENSAR, Inc.

Equities

LNSR

US52634L1089

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 02:00:00 27/04/2024 am IST 5-day change 1st Jan Change
3.24 USD -5.54% Intraday chart for LENSAR, Inc. +0.31% -7.69%

Business Summary

LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its product portfolio consists of the LENSAR Laser System and ALLY Adaptive Cataract Treatment System (ALLY System) and its associated consumable components. The system incorporates a range of technologies designed to assist the surgeon in obtaining visual outcomes. The consumable portion of the system consists of a disposable patient interface device kit. The ALLY System is designed to combine its femtosecond laser technology features with enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room or in-office surgical suite. Its system is used across surgeons, hospital outpatient surgical facilities and ambulatory surgery centers.

Number of employees: 130

Sales per Business

USD in Million2022Weight2023Weight Delta
LENSAR Laser System
75.0 %
26 73.4 % 32 75.0 % +21.90%
Lease
15.3 %
6 16.7 % 6 15.3 % +9.01%
Service
9.7 %
3 9.9 % 4 9.7 % +16.91%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
59.9 %
19 53.1 % 25 59.9 % +34.54%
Global
15.3 %
6 16.7 % 6 15.3 % +9.01%
Europe
13.2 %
4 12.5 % 6 13.2 % +26.67%
Asia (excluding South Korea)
9.1 %
4 10.1 % 4 9.1 % +7.27%
Other
1.8 %
1 1.4 % 1 1.8 % +54.58%
South Korea
0.6 %
2 6.2 % 0 0.6 % -88.21%

Managers

Managers TitleAgeSince
Chief Executive Officer 68 01/10/01
Director of Finance/CFO 56 01/20/01
Chief Operating Officer 52 01/08/01
Comptroller/Controller/Auditor 44 01/21/01

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 68 01/10/01
Director/Board Member 54 25/23/25
Director/Board Member 76 02/18/02
Chairman 78 08/17/08
Director/Board Member 55 01/21/01
Director/Board Member 56 25/23/25
Director/Board Member 59 01/21/01
Director/Board Member 64 01/18/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 11,395,245 9,404,636 ( 82.53 %) 0 82.53 %

Shareholders

NameEquities%Valuation
Park West Asset Management LLC
9.791 %
1,115,686 9.791 % 4 M $
North Run Capital LP
9.659 %
1,100,592 9.659 % 4 M $
748,350 6.567 % 3 M $
Dimensional Fund Advisors LP
5.798 %
660,682 5.798 % 2 M $
Bill Link
4.493 %
511,979 4.493 % 2 M $
Vanguard Global Advisers LLC
3.804 %
433,474 3.804 % 1 M $
Renaissance Technologies LLC
2.759 %
314,438 2.759 % 1 M $
254,971 2.238 % 866 136 $
DCF Advisers LLC
2.111 %
240,534 2.111 % 817 094 $
Brandes Investment Partners LP
1.989 %
226,676 1.989 % 770 018 $
NameEquities%Valuation
North Run Capital LP
-
20,000 - 67 940 $

Company contact information

LENSAR, Inc.

2800 Discovery Drive

32826, Orlando

+

http://www.lensar.com
address LENSAR, Inc.(LNSR)